NEW YORK (GenomeWeb) – Beta-blocker treatment may undo some of the gene expression changes that occur in heart failure, according to a new study.

Beta-blockers are commonly used to treat cardiac conditions, including heart failure, and they target myocyte enhancer factor 2 (MEF2) proteins, which are involved in cardiac remodeling.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.